The governmental decree published on 22 February (No. 33/2024 (II. 22.)) sets forth the establishment of a new project company to manage the provision of inpatient pharmaceuticals in all public hospitals, as well as those private hospitals that choose to join the initiative. The Decree is a follow up to the amendments in the Medicines Thrift Act (Act XCVIII of 2006) from July 2023, which stipulated the basic conditions for a “unified institutional pharmacy service” for public hospitals. The project company shall be operational from January 2025.

JDP has advised Axon Lab on its acquisition of Color Trading.

Rizoiu & Poenaru, working with Clifford Chance, has advised the Affidea Group on its acquisition of cancer care provider MedEuropa Romania. Biris Goran, working with Linklaters, advised the sellers.

Turunc has advised the Future Impact Fund on its investment in precision medicine biotechnology company PhiTech Bioinformatics. The Aksan law firm advised PhiTech on the Maxis Arya Venture Capital Fund-led investment round.

The President of Ukraine has officially signed Law No. 3528-IX “On Amendments to Certain Laws of Ukraine Regarding the State Regulation of Cannabis Plants for Use in Educational Purposes, Educational, Scientific and Scientific-Technical Activities, drugs production, Psychotropic Substances and medicinal products with the aim of increasing patients’ access to the necessary treatment” simply known as the law on cannabis legalisation (the “Medical Cannabis Law”). The Medical Cannabis Law sets forth regulations governing the use of cannabis for educational, scientific, and medical purposes.

SSK&W has advised Tangent Line Ventures and Peleton on their investment into MIM Fertility. Domanski Zakrzewski Palinka advised MIM Fertility.